Coronary artery surgery for ischemic heart failure: Risks, benefits, and the importance of assessment of myocardial viability

Cowie, 1999, Incidence and aetiology of heart failure; A population-based study, Eur Heart J, 20, 421, 10.1053/euhj.1998.1280 Mosterd, 1999, Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam study, Eur Heart J, 20, 447, 10.1053/euhj.1998.1239 Ho, 1993, The epidemiology of heart failure: The Framingham study, J Am Coll Cardiol, 22, 6A, 10.1016/0735-1097(93)90455-A Teerlink, 1991, An overview of contemporary etiologies of congestive heart failure, Am Heart J, 121, 1852, 10.1016/0002-8703(91)90072-P McDonagh, 1997, Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population, Lancet, 350, 829, 10.1016/S0140-6736(97)03033-X Murdoch, 1998, Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992, Eur Heart J, 19, 1829, 10.1053/euhj.1998.1269 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 CIBIS II Investigational Committees, 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 The Acute Infarction Ramipril Efficacy AIRE Study Investigators, 1993, Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure, Lancet, 342, 821 Køber, 1995, A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 333, 1670, 10.1056/NEJM199512213332503 Cohn, 1993, Ejection fraction, oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure, Circulation, 87, VI5 Braunwald, 1989, Myocardial reperfusion limitation of infarct size, reduction of left ventricular dysfunction and improved survival. Should the paradigm be expanded, Circulation, 79, 441, 10.1161/01.CIR.79.2.441 Lee, 1994, Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularisation, Circulation, 90, 2687, 10.1161/01.CIR.90.6.2687 Diamond, 1978, Post-extrasystolic potentiation of ischaemic cardiomyopathy by atrial stimulation, Am Heart J, 95, 204, 10.1016/0002-8703(78)90464-7 Rahimtoola, 1989, The hibernating myocardium, Am Heart J, 117, 211, 10.1016/0002-8703(89)90685-6 Bolli, 1988, Oxygen-derived free radicals and postischaemic myocardial dysfunction “stunned myocardium”, J Am Coll Cardiol, 12, 239, 10.1016/0735-1097(88)90381-6 Camici, 1997, Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium), Circulation, 96, 3205, 10.1161/01.CIR.96.9.3205 Ficaro, 1995, Simultaneous transmission-emission thallium-201 cardiac SPECT: Effect of attenuation correction on myocardial tracer distribution, J Nucl Med, 36, 921 Matsunari, 1998, Attenuation-corrected 99m Tc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: Comparison with positron emission tomography using 18 F-Fluorodeoxyglucose, J Am Coll Cardiol, 32, 927, 10.1016/S0735-1097(98)00340-4 Tillisch, 1986, Reversibility of cardiac wall-motion abnormalities predicted by positron tomography, N Engl J Med, 314, 884, 10.1056/NEJM198604033141405 Cornel, 1998, Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease—Implications of time course of recovery on diagnostic accuracy, J Am Coll Cardiol, 31, 1002, 10.1016/S0735-1097(98)00067-9 Baer, 1998, Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularisation, J Am Coll Cardiol, 31, 1040, 10.1016/S0735-1097(98)00032-1 Favaloro, 1968, Saphenous vein autograft replacement of severe segmental coronary artery occlusion: Operative technique, Ann Thor Surg, 5, 334, 10.1016/S0003-4975(10)66351-5 Alderman, 1983, Results of coronary artery surgery in patients with poor left ventricular function (CASS), Circulation, 4, 785, 10.1161/01.CIR.68.4.785 Varnauskas, 1988, Twelve-year follow-up of survival in the randomised European Coronary Surgery Study, N Engl J Med, 319, 332, 10.1056/NEJM198808113190603 The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group, 1984, Eleven-year survival in the veterans administration randomised trial of coronary bypass surgery for stable angina, N Engl J Med, 311, 1333, 10.1056/NEJM198411223112102 Yusuf, 1994, Effect of coronary artery bypass graft on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialist Collaboration, Lancet, 344, 563, 10.1016/S0140-6736(94)91963-1 Harris, 1979, Survival in medically treated coronary artery disease, Circulation, 60, 1259, 10.1161/01.CIR.60.6.1259 Mock, 1982, Survival of medically treated patients in the Coronary Artery Surgery Study (CASS), Circulation, 66, 562, 10.1161/01.CIR.66.3.562 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Swedberg, 1999, Long-term survival in severe heart failure in patients treated with enalapril; ten year follow-up of CONSENSUS I, Eur Heart J, 20, 136, 10.1053/euhj.1998.1098 Rahimtoola, 1985, A perspective on the three large multicenter randomized clinical trials of coronary artery bypass surgery for chronic stable angina, Circulation, 72, V123 Passamani, 1985, A randomised trial of coronary artery bypass surgery. Survival of patients with low ejection fraction, N Engl J Med, 312, 1665, 10.1056/NEJM198506273122603 Bounous, 1988, Surgical survival benefit for coronary disease patients with left ventricular dysfunction, Circulation, 78, 151 Pigott, 1985, Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function, J Am Coll Cardiol, 5, 1036, 10.1016/S0735-1097(85)80003-6 Hochberg, 1983, Coronary artery bypass grafting in patients with ejection fractions below forty percent, J Thorac Cardiovasc Surg, 86, 519, 10.1016/S0022-5223(19)39116-0 Braunwald, 1986, Reversible ischaemic left ventricular dysfunction: Evidence for “hibernating myocardium”, J Am Coll Cardiol, 8, 1467, 10.1016/S0735-1097(86)80325-4 Faulkner, 1977, Ischaemic cardiomyopathy medical versus surgical treatment, J Thorac Cardiovasc Surg, 74, 77, 10.1016/S0022-5223(19)41417-7 Kron, 1989, Coronary revascularization rather than cardiac transplantation for chronic ischaemic cardiomyopathy, Ann Surg, 210, 348, 10.1097/00000658-198909000-00011 Louie, 1991, Ischaemic cardiomyopathy. Criteria for myocardial revascularisation and cardiac transplantation, Circulation, 86, 290 Milano, 1993, Coronary artery bypass in patients with severely depressed ventricular function, Ann Thor Surg, 56, 487, 10.1016/0003-4975(93)90884-K Luciani, 1993, Severe ischaemic left ventricular failure: Coronary operation or heart transplantation?, Ann Thor Surg, 55, 719, 10.1016/0003-4975(93)90282-M Elefteriades, 1993, Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state, J Am Coll Cardiol, 22, 1411, 10.1016/0735-1097(93)90551-B Lansman, 1993, Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: Long term follow-up, Ann Thor Surg, 56, 480, 10.1016/0003-4975(93)90883-J Dreyfus, 1994, Myocardial viability assessment in ischaemic cardiomyopathy: Benefits of coronary revascularisation, Ann Thor Surg, 57, 1402, 10.1016/0003-4975(94)90091-4 Mickleborough, 1995, Results of revascularisation in patients with severe left ventricular dysfunction, Circulation, 92, 73, 10.1161/01.CIR.92.9.73 Pagley, 1997, Improved outcome after coronary artery bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability, Circulation, 96, 793, 10.1161/01.CIR.96.3.793 Gunning, 1997, Hibernating myocardium: Clinical and functional response to revascularisation, Eur J Cardiothorac Surg, 11, 1105, 10.1016/S1010-7940(97)01211-6 Haas, 1997, Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease, J Am Coll Cardiol, 30, 1693, 10.1016/S0735-1097(97)00375-6 Pagano, 1998, Coronary artery bypass grafting for ischemic heart failure. The predictive value of quantitative PET for symptomatic and functional outcome, J Thorac Cardiovasc Surg, 115, 791, 10.1016/S0022-5223(98)70357-5 Di Carli, 1998, Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions, J Thorac Cardiovasc Surg, 116, 997, 10.1016/S0022-5223(98)70052-2 Meluzin, 1998, Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction, J Am Coll Cardiol, 32, 912, 10.1016/S0735-1097(98)00324-6 Bax, 1999, Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography, J Am Coll Cardiol, 34, 163, 10.1016/S0735-1097(99)00157-6 Chaudry, 1999, Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction, J Am Coll Cardiol, 34, 730, 10.1016/S0735-1097(99)00252-1 Auerbach, 1999, Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy, Circulation, 99, 2921, 10.1161/01.CIR.99.22.2921 Afridi, 1998, Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction, J Am Coll Cardiol, 32, 921, 10.1016/S0735-1097(98)00321-0 Al-Mohammad, 1998, Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles, Heart, 80, 559, 10.1136/hrt.80.6.559 Senior, 1999, Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure, J Am Coll Cardiol, 33, 1848, 10.1016/S0735-1097(99)00102-3 Pasquet, 1999, Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction, Circulation, 100, 141, 10.1161/01.CIR.100.2.141 Eitzman, 1992, Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography, J Am Coll Cardiol, 20, 559, 10.1016/0735-1097(92)90008-B Pagano, 1999, Coronary revascularisation for postischaemic heart failure: How myocardial viability affects survival, Heart, 82, 684, 10.1136/hrt.82.6.684 Bax, 1997, Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography, J Am Coll Cardiol, 30, 377, 10.1016/S0735-1097(97)00174-5 Beanlands, 1998, Delay in revascularisation is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission imaging, Circulation, 98, 51 Schwarz, 1998, Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularisation, J Am Coll Cardiol, 31, 1018, 10.1016/S0735-1097(98)00041-2 Ausma, 1995, Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation, J Mol Cell Cardiol, 27, 1202, 10.1016/0022-2828(95)90056-X Maes, 1994, Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings, Circulation, 90, 735, 10.1161/01.CIR.90.2.735 Ausma, 1995, Chronic hibernating myocardium: Interstitial changes, Mol Cell Biochem, 147, 35, 10.1007/BF00944781 Depre', 1995, Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans, Am J Physiol, 268, H1265 Schwarz, 1996, Myocyte degeneration and cell death in hibernating myocardium, J Am Coll Cardiol, 27, 1577, 10.1016/0735-1097(96)00059-9 Nagueh, 1999, Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans, Circulation, 100, 490, 10.1161/01.CIR.100.5.490 Chen, 1997, Myocardial cell death and apoptosis in hibernating myocardium, J Am Coll Cardiol, 30, 1407, 10.1016/S0735-1097(97)00309-4 Ohno, 1998, “Apoptotic” myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation. Analysis by immunogold electron microscopy combined with in situ nick end-labeling, Circulation, 98, 1422, 10.1161/01.CIR.98.14.1422 Olivetti, 1997, Apoptosis in the failing human heart, N Engl J Med, 336, 1131, 10.1056/NEJM199704173361603 Colucci, 1996, Apoptosis in the heart, N Engl J Med, 335, 1224, 10.1056/NEJM199610173351610 Fath-Ordoubadi, 1999, Efficacy of coronary angioplasty for the treatment of hibernating myocardium, Heart, 82, 210, 10.1136/hrt.82.2.210 Di Carli, 1994, Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction, Am J Cardiol, 73, 527, 10.1016/0002-9149(94)90327-1